AJP - Endo Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 296: E440-E444, 2009. First published January 13, 2009; doi:10.1152/ajpendo.90505.2008
0193-1849/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
296/3/E440    most recent
90505.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bokhari, S.
Right arrow Articles by Meyer, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bokhari, S.
Right arrow Articles by Meyer, C.

Metabolic fate of plasma glucose during hyperglycemia in impaired glucose tolerance: evidence for further early defects in the pathogenesis of type 2 diabetes

Syed Bokhari, Peter Emerson, Zarmen Israelian, Anchal Gupta, and Christian Meyer

Department of Endocrinology, Carl T. Hayden Veterans Affairs Medical Center, Phoenix, Arizona

Submitted 11 June 2008 ; accepted in final form 4 January 2009

We examined the intracellular metabolic fate of plasma glucose during a hyperglycemic clamp in impaired glucose-tolerant (IGT; n = 21) and normal glucose-tolerant subjects (n = 10) using a combination of [3-3H]glucose infusion with measurement of [3H]water formation and indirect calorimetry. IGT was associated with ~35% reduced first-phase insulin responses, normal second-phase insulin response, and 25–30% reduced insulin sensitivity, resulting in ~35% reduced plasma glucose disposal. This was coupled with ~55% reduced storage of plasma glucose (P < 0.01) and ~15–20% reduced glycolysis of plasma glucose (P < 0.03), accounting for ~75 and 25% of the reduction in glucose disposal, respectively. Decreased glucose oxidation accounted for virtually all the decrease in glycolysis. Therefore, nonoxidative glycolysis of plasma glucose in IGT was similar to that in NGT (P > 0.9) and accounted for an increased proportion of systemic glucose disposal (P < 0.05). We conclude that, in IGT, decreased disposal of plasma glucose involves mainly decreased glycogen synthesis and to a lesser extent decreased glycolysis, which is accounted for by decreased glucose oxidation. An increased proportion of plasma glucose hence undergoes nonoxidative glycolysis, representing a novel early abnormality in the pathogenesis of T2DM.

glucose oxidation; glycogen synthesis; glycolysis



Address for reprint requests and other correspondence: C. Meyer, Carl T. Hayden VA Medical Center, 650 East Indian School Road, Phoenix, AZ 85012 (e-mail: christian.meyer{at}va.gov)




This article has been cited by other articles:


Home page
Diabetes CareHome page
E. L. Dillon and M. Sheffield-Moore
Novel Noninvasive Breath Test Method for Screening Individuals at Risk for Diabetes: Response to Davidson
Diabetes Care, July 1, 2009; 32(7): e89 - e89.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.